Cargando…
Current status of development of methylation biomarkers for in vitro diagnostic IVD applications
A significant volume of research clearly shows that disease-related methylation changes can be used as biomarkers at all stages of clinical disease management, including risk assessment and predisposition screening through early diagnostics to personalization of patient care and monitoring of the re...
Autores principales: | Taryma-Leśniak, Olga, Sokolowska, Katarzyna Ewa, Wojdacz, Tomasz Kazimierz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336678/ https://www.ncbi.nlm.nih.gov/pubmed/32631437 http://dx.doi.org/10.1186/s13148-020-00886-6 |
Ejemplares similares
-
Correction to: Current status of development of methylation biomarkers for in vitro diagnostic IVD applications
por: Taryma-Leśniak, Olga, et al.
Publicado: (2020) -
eDAVE – Extension of GDC data analysis, visualization, and exploration tools
por: Bińkowski, Jan, et al.
Publicado: (2023) -
Influence of Unequal Amplification of Methylated and Non-Methylated Template on Performance of Pyrosequencing
por: Taryma-Lesniak, Olga, et al.
Publicado: (2022) -
Long-Term Treatment with Bortezomib Induces Specific Methylation Changes in Differentiated Neuronal Cells
por: Łuczkowska, Karolina, et al.
Publicado: (2022) -
Bortezomib induces methylation changes in neuroblastoma cells that appear to play a significant role in resistance development to this compound
por: Łuczkowska, Karolina, et al.
Publicado: (2021)